Last updated
Thalassemia trait (thalassemia minor) is a carrier state that usually causes no illness. But if both partners are carriers, each pregnancy has a 25% chance of a baby with thalassemia major. A simple blood test (CBC plus hemoglobin HPLC) before marriage or early in pregnancy identifies carriers, and prenatal testing can tell whether the baby is affected.
What is thalassemia trait?
Thalassemia is inherited. A person who inherits one altered beta-globin gene from one parent has beta-thalassemia trait (also called thalassemia minor or carrier). Carriers are generally healthy. They may have mild anemia with small red cells, which is often mistaken for iron deficiency. Beta-thalassemia trait is common in India, with roughly 3–4 in every 100 people estimated to be carriers.
Why does it matter for couples?
If only one partner is a carrier, children cannot have thalassemia major (though they may be carriers). If both partners are carriers, in every pregnancy there is:
- a 25% (1 in 4) chance the baby has thalassemia major, which needs lifelong blood transfusions or a bone marrow transplant;
- a 50% (2 in 4) chance the baby is a carrier like the parents;
- a 25% (1 in 4) chance the baby is unaffected.
Testing in advance lets families make informed choices.
Which test should you do?
- Complete blood count (CBC): carriers usually have a low MCV and MCH (small, pale red cells), often with a normal or high red cell count.
- Hemoglobin HPLC (or electrophoresis): a raised HbA2 level, usually above 3.5%, suggests beta-thalassemia trait. HPLC also detects other hemoglobin variants such as HbS (sickle) and HbE.
Iron deficiency can lower HbA2 and hide the trait, so a doctor may check iron levels and repeat testing if needed. Alpha-thalassemia trait may not show on HPLC and may need DNA testing.
When to test
- Ideally before marriage, or at least before planning a pregnancy.
- If you are already pregnant, test the mother early in pregnancy; if she is a carrier, test the father promptly.
- Anyone with small red cells (low MCV) that does not improve with iron should be tested.
- Relatives of a known carrier or of a child with thalassemia.
What if both partners are carriers?
Meet a hematologist or genetic counsellor. During pregnancy, prenatal diagnosis (usually chorionic villus sampling at about 10–13 weeks) can show whether the baby is affected, so the family can decide on the next steps with full information. Couples planning a pregnancy may also discuss options such as pre-implantation genetic testing with IVF.
Does a carrier need treatment?
Usually no. Carriers do not need regular transfusions. Importantly, they should not take iron tablets unless iron deficiency is confirmed, as unnecessary iron can build up in the body. Folic acid may be advised in pregnancy.
Can thalassemia major be treated without lifelong transfusions?
For eligible patients, a bone marrow transplant, ideally in early childhood with a suitable family donor, is an established treatment that can remove the need for lifelong transfusions. Gene therapy is an emerging option. A hematologist can advise whether transplant, or continued transfusion and iron chelation, is appropriate in an individual case.
This guide is general health information and is not a substitute for a consultation. Reference ranges and recommendations can differ between laboratories and individuals.